Press release
Kaposi's Sarcoma Market 2032: Epidemiology Data, Pipeline Breakthroughs, Regulatory Landmarks by DelveInsight | Vasgene Therapeutics, University of California, Navidea Biopharmaceuticals, Parirenyatwa Hospital, ImmunityBio, Inc., Vasgene Therapeutics, Inc
To Know in detail about the Kaposi's Sarcoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Kaposi's Sarcoma Market Forecast
https://www.delveinsight.com/sample-request/kaposis-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Kaposi's Sarcoma Market Report:
• The Kaposi's Sarcoma market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• A study by Stiller et al. (2021) gathered data from 59 population-based cancer registries across 22 countries. The study revealed that, for the years of diagnosis between 2000 and 2007, and observing trends from 1995 to 2007, the crude annual incidence rate of the disease was 0.28 per 100,000 people, while the age-adjusted incidence rate was 0.23 per 100,000 people.
• The anticipated launch of Kaposi's Sarcoma pipeline therapies, including sEphB4-HSA from Vasgene Therapeutics and others, is expected to drive market growth during the forecast period from 2023 to 2032.
• Key Kaposi's Sarcoma Companies: Vasgene Therapeutics, University of California, Navidea Biopharmaceuticals, Parirenyatwa Hospital, ImmunityBio, Inc., Vasgene Therapeutics, Inc, AIDS Malignancy Consortium, Anderson Clinical Research, Ligand Pharmaceuticals, Otsuka America Pharmaceutical, Hoffmann-La Roche, Sequus Pharma, Abbott, SUGEN, and others
• Key Kaposi's Sarcoma Therapies: sEphB4-HSA, Maraviroc, Tc 99m tilmanocept, abacavir/3TC/zidovudine, aldoxorubicin, sEphB4-HSA, imatinib mesylate, Alitretinoin, Bexarotene, Vesnarinone, Ro 24-7429, Doxorubicin hydrochloride (liposomal), Ritonavir, SU5416l, and others
• The Kaposi's Sarcoma epidemiology based on gender analyzed that Kaposi's Sarcoma is more common in males than in females
• The Kaposi's Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Kaposi's Sarcoma pipeline products will significantly revolutionize the Kaposi's Sarcoma market dynamics.
Kaposi's Sarcoma Overview
Kaposi's Sarcoma (KS) is a type of cancer that originates from the endothelial cells lining the blood vessels and lymph vessels. It presents as tumors or lesions on the skin, but it can also affect internal organs, including the lymph nodes, lungs, and gastrointestinal tract. KS is associated with an infection by Human Herpesvirus 8 (HHV-8), also known as Kaposi's Sarcoma-associated Herpesvirus (KSHV).
Get a Free sample for the Kaposi's Sarcoma Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/kaposis-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Kaposi's Sarcoma Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Kaposi's Sarcoma Epidemiology Segmentation:
The Kaposi's Sarcoma market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Kaposi's Sarcoma
• Prevalent Cases of Kaposi's Sarcoma by severity
• Gender-specific Prevalence of Kaposi's Sarcoma
• Diagnosed Cases of Episodic and Chronic Kaposi's Sarcoma
Download the report to understand which factors are driving Kaposi's Sarcoma epidemiology trends @ Kaposi's Sarcoma Epidemiology Forecast
https://www.delveinsight.com/sample-request/kaposis-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Kaposi's Sarcoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Kaposi's Sarcoma market or expected to get launched during the study period. The analysis covers Kaposi's Sarcoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Kaposi's Sarcoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Kaposi's Sarcoma Therapies and Key Companies
• sEphB4-HSA: Vasgene Therapeutics
• Maraviroc: University of California
• Tc 99m tilmanocept: Navidea Biopharmaceuticals
• abacavir/3TC/zidovudine: Parirenyatwa Hospital
• aldoxorubicin: ImmunityBio, Inc.
• sEphB4-HSA: Vasgene Therapeutics, Inc
• imatinib mesylate: AIDS Malignancy Consortium
• Alitretinoin: Anderson Clinical Research
• Bexarotene: Ligand Pharmaceuticals
• Vesnarinone: Otsuka America Pharmaceutical
• Ro 24-7429: Hoffmann-La Roche
• Doxorubicin hydrochloride (liposomal): Sequus Pharmaceuticals
• Ritonavir: Abbott
• SU5416: SUGEN
Discover more about therapies set to grab major Kaposi's Sarcoma market share @ Kaposi's Sarcoma Treatment Landscape
https://www.delveinsight.com/sample-request/kaposis-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Kaposi's Sarcoma Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Kaposi's Sarcoma Companies: Vasgene Therapeutics, University of California, Navidea Biopharmaceuticals, Parirenyatwa Hospital, ImmunityBio, Inc., Vasgene Therapeutics, Inc, AIDS Malignancy Consortium, Anderson Clinical Research, Ligand Pharmaceuticals, Otsuka America Pharmaceutical, Hoffmann-La Roche, Sequus Pharma, Abbott, SUGEN, and others
• Key Kaposi's Sarcoma Therapies: sEphB4-HSA, Maraviroc, Tc 99m tilmanocept, abacavir/3TC/zidovudine, aldoxorubicin, sEphB4-HSA, imatinib mesylate, Alitretinoin, Bexarotene, Vesnarinone, Ro 24-7429, Doxorubicin hydrochloride (liposomal), Ritonavir, SU5416, and others
• Kaposi's Sarcoma Therapeutic Assessment: Kaposi's Sarcoma current marketed and Kaposi's Sarcoma emerging therapies
• Kaposi's Sarcoma Market Dynamics: Kaposi's Sarcoma market drivers and Kaposi's Sarcoma market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Kaposi's Sarcoma Unmet Needs, KOL's views, Analyst's views, Kaposi's Sarcoma Market Access and Reimbursement
To know more about Kaposi's Sarcoma companies working in the treatment market, visit @ Kaposi's Sarcoma Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/kaposis-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Kaposi's Sarcoma Market Report Introduction
2. Executive Summary for Kaposi's Sarcoma
3. SWOT analysis of Kaposi's Sarcoma
4. Kaposi's Sarcoma Patient Share (%) Overview at a Glance
5. Kaposi's Sarcoma Market Overview at a Glance
6. Kaposi's Sarcoma Disease Background and Overview
7. Kaposi's Sarcoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Kaposi's Sarcoma
9. Kaposi's Sarcoma Current Treatment and Medical Practices
10. Kaposi's Sarcoma Unmet Needs
11. Kaposi's Sarcoma Emerging Therapies
12. Kaposi's Sarcoma Market Outlook
13. Country-Wise Kaposi's Sarcoma Market Analysis (2019-2032)
14. Kaposi's Sarcoma Market Access and Reimbursement of Therapies
15. Kaposi's Sarcoma Market Drivers
16. Kaposi's Sarcoma Market Barriers
17. Kaposi's Sarcoma Appendix
18. Kaposi's Sarcoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports by DelveInsight
Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Dermatitis Seborrheic Market https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastro Intestinal Bleeding Market https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.
Point Of Care Glucose Testing Market https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Substance Drug Abuse Market https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kaposi's Sarcoma Market 2032: Epidemiology Data, Pipeline Breakthroughs, Regulatory Landmarks by DelveInsight | Vasgene Therapeutics, University of California, Navidea Biopharmaceuticals, Parirenyatwa Hospital, ImmunityBio, Inc., Vasgene Therapeutics, Inc here
News-ID: 3508782 • Views: …
More Releases from DelveInsight Business Research
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics.
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,…
Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast
https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Kaposi
Kaposi Sarcoma Market forecast period 2023-2020
This Kaposi Sarcoma Market sector is rapidly evolving, with substantial growth and advancements expected by 2031. In-depth market research offers a comprehensive analysis of market size, share, and trends, providing crucial insights into its expansion. The report explores market segmentation and definitions, elucidating key components and drivers. Utilizing SWOT and PESTEL analyses, it evaluates the market's strengths, weaknesses, opportunities, and threats, as well as political, economic, social, technological, environmental, and legal factors.…
Kaposi Sarcoma Market : Current Trends & Opportunities by 2024
The global market for Kaposi sarcoma is highly consolidated in nature with two players holding a massive share of the market, states a new market intelligence study that’s has been recently published by Transparency Market Research. In 2015, the two leading players, namely Merck & Co. Inc. and Johnson & Johnson held a share of around 50% of the global market and is projected to remain in the similar situation…
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market Research Report Forecast to 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kapos …
Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the…
